Bedminster, NJ, United States of America

Marilyn A Apfel

This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Marilyn A. Apfel

Introduction

Marilyn A. Apfel is a notable inventor based in Bedminster, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug coatings. Her innovative approach has led to advancements in the delivery of water-insoluble drugs.

Latest Patents

Marilyn A. Apfel holds 1 patent for her invention titled "Water insoluble drugs coated by coacervated fish gelatin." This invention involves the combination of a solid particulate water-insoluble drug with a solid fish gelatin coating produced through coacervation. The unique aspect of her invention is that the fish gelatin is soluble at ambient temperatures, allowing for relatively low-temperature coacervation, which is not possible with other gelatins. The process is enhanced by the addition of conventional coacervation agents, and the resulting coacervating suspension is rendered insoluble by a suitable fixative such as glutaraldehyde.

Career Highlights

Marilyn A. Apfel has had a distinguished career, working at Warner-Lambert Company, where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to the advancement of pharmaceutical technologies, particularly in drug formulation and delivery systems.

Collaborations

Throughout her career, Marilyn has collaborated with notable colleagues, including Isaac Ghebre-Sellassie and Russell U. Nesbitt. These collaborations have further enriched her work and contributed to the success of her inventions.

Conclusion

Marilyn A. Apfel's contributions to the field of pharmaceuticals through her innovative patent demonstrate her commitment to advancing drug delivery technologies. Her work continues to impact the industry positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…